A prosecutor’s office in charge of investigating the misuse of public funds is probing the Arab Company for Drug Industries and Medical Appliances (ACDIMA) amid allegations it engaged in monopolistic practices that resulted in a penicillin shortage in the local market, Al Masry Al Youm reports. The Health Ministry is reportedly accusing ACDIMA’s former president, Medhat Shaarawi, of halting an incoming shipment of penicillin and rerouting the shipment through a company owned by one of his family members. The ministry alleges that was behind the penicillin shortage citizens began complaining about earlier this month. Shaarawi has denied the allegations.